세계의 멀티오믹스 시장 규모는 2024년 27억 달러에서 예측 기간 중 CAGR 13.5%로 추이하며, 2029년말에는 51억 달러 규모에 달할 것으로 예측됩니다.
소모품 부문은 2024년 16억 달러에서 CAGR 14.1%로 추이하며, 2029년말에는 31억 달러에 달할 것으로 예측됩니다. 또한 기기 부문은 2024년 6억 2,990만 달러에서 CAGR 12.4%로 추이하며, 2029년말에는 11억 달러에 달할 것으로 예측됩니다.
세계의 멀티오믹스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신규 기술 및 기술개발 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 개요
제2장 시장 개요
개요
기술 배경
오믹스 유형
다양한 멀티오믹스 어프로치와 용도
기술 인프라와 데이터 통합
PESTEL 분석
규제 상황
전략적 권장사항
제3장 시장 역학
시장 역학
시장 성장 촉진요인
멀티오믹스 연구와 용도의 급속한 진보
멀티오믹스 연구에 대한 양호한 자금조달 시나리오
DNA 시퀀싱의 가격 저하
암이환율의 증가에 의해 개별화 치료의 수요가 증가
의약품 개발 프로세스에서 멀티오믹스의 유망한 용도
시장 성장 억제요인
데이터 표준화의 결여
시장 기회
단세포 멀티오믹스 용도의 확대
제4장 신규 기술과 개발
멀티오믹스용 AI
AI 멀티오믹스 시장의 기업
단세포 오믹스와 멀티오믹스의 진보
제5장 시장 세분화 분석
주요 시장 동향
세분화 내역
세계의 멀티오믹스 시장 : 제품별
기기
소모품
소프트웨어와 서비스
세계의 멀티오믹스 시장 : 플랫폼별
유전체학
단백질체학
전사체학
대사체학
기타
세계의 멀티오믹스 시장 : 용도별
종양
면역
신경
세포 생물
기타
세계의 멀티오믹스 시장 : 최종사용자별
학술연구기관
제약·바이오테크놀러지 기업
임상 실험실·원내 실험실
기타
지역적 내역
세계의 멀티오믹스 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 정보
주요 기업 순위
기업의 채택 전략
협업과 파트너십
신제품의 발매
확장과 투자
M&A
합의 사항
특허 분석
제7장 멀티오믹스 시장의 지속가능성 : ESG 관점
ESG : 서론
시장에서의 ESG 퍼포먼스
멀티오믹스 업계에서의 ESG 실천
BCC로부터의 결론
제8장 부록
조사 방법
두자어
참고 문헌
기업 개요
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC.(SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BD
BRUKER
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.
KSA
영문 목차
영문목차
The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.
The global market for multiomics for consumables is expected to grow from $1.6 billion in 2024 and is projected to reach $3.1 billion by the end of 2029, at a CAGR of 14.1% during the forecast period of 2024 to 2029.
The global market for multiomics for instruments is expected to grow from $629.9 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.
Report Scope:
This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.
Report Includes:
51 data tables and 55 additional tables
An analysis of the current and future global markets for multiomics
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding.
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Technology Background
Omics Types
Various Multiomics Approaches and Applications
Technological Infrastructure and Data Integration
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Regulatory Landscape
Federal Regulation
CMS Regulation
U.S. Food and Drug Administration Regulation
U.S. Federal Trade Commission Regulation
Strategic Recommendations
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rapid Advances in Multiomics Research and its Applications
Favorable Funding Scenario for Multiomics Research Activities
Decrease in DNA-Sequencing Method Prices
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Promising Applications of Multiomics in the Drug Development Process
Market Restraints
Lack of Data Standardization
Market Opportunities
Expanding Single-Cell Multiomics Applications
Chapter 4 Emerging Technologies and Developments
Artificial Intelligence in Multiomics
Companies in the Artificial Intelligence Multiomics Market
Advances in Single-Cell Omics and Multiomics
Chapter 5 Market Segmentation Analysis
Key Market Trends
Segmentation Breakdown
Global Market for Multiomics by Product
Instruments
Consumables
Software and Services
Global Market for Multiomics by Platform
Genomics
Proteomics
Transcriptomics
Metabolomics
Other Platforms
Global Market for Multiomics by Application
Oncology
Immunology
Neurology
Cell Biology
Other Applications
Global Market for Multiomics by End User
Academic Research Organizations
Pharmaceutical and Biotechnology Companies
Clinical and Hospital Laboratories
Other End Users
Geographic Breakdown
Global Multiomics Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Top Players Ranking
Key Strategies Adopted by Players
Collaborations and Partnerships
New Product Launches
Expansions and Investments
Mergers and Acquisitions
Agreements
Patent Analysis
Chapter 7 Sustainability in Multiomics Market: ESG Perspective
Introduction to ESG
ESG Performance in Market
ESG Practices in the Multiomics Industry
Concluding Remarks from BCC Research
Chapter 8 Appendix
Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
